Anti-Human APP Therapeutic Antibody (Lym116)

Ask supplier a question | View on supplier's website

The anti-beta-amyloid antibody target beta-amyloid of which the accumulation can result the pathogenesis of AD. By lowering the Aβ burden, the antibody can be used in the immunotherapy of neurological disorders, such as Alzheimer's disease.

Supplier	Creative Biolabs
Product #	TAB-0788CLV
Pricing	Inquiry
Type	Fully human antibody
Host	Human
Target	Amyloid beta

Feedback